ClinConnect ClinConnect Logo
Search / Trial NCT05240703

Stabilization Splint Treatment of TMD

Launched by UNIVERSITY OF OULU · Feb 3, 2022

Trial Information

Current as of May 14, 2025

Completed

Keywords

Temporomandibular Disorders Tmd Facial Pain Treatment Stabilization Splint Clinical Trial

ClinConnect Summary

DESIGN OF THE STUDY The study sample consisted originally of 80 patients (18 men, 62 women) who were referred to the Oral and Maxillofacial Department in Oulu University Hospital, Oulu, Finland, for treatment of TMD-related facial pain. The patients were examined between March 2008 and August 2010. The inclusion criteria were the following: 1. clinically diagnosed TMD as defined by the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) (1), 2. minimum of 20 years of age and 3. lack of long-term illnesses (i.e. rheumatoid arthritis) that may affect TMJs or the masticatory...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • clinically diagnosed TMD according to the RDC/TMD
  • age \> 20 years
  • Exclusion Criteria:
  • • Presence of any chronic diseases, such as rheumatoid arthritis, that may affect the TMJ or the masticatory muscles

About University Of Oulu

The University of Oulu, located in Finland, is a leading research institution known for its commitment to advancing scientific knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the University of Oulu leverages its extensive academic expertise, state-of-the-art facilities, and collaborative networks to conduct rigorous and ethically sound clinical research. The university emphasizes interdisciplinary approaches and strives to translate research findings into practical applications that improve patient outcomes and contribute to public health. Through its clinical trials, the University of Oulu aims to foster advancements in medical science while adhering to the highest standards of integrity and compliance.

Locations

Patients applied

0 patients applied

Trial Officials

Kirsi Sipilä, Professor

Principal Investigator

Research Unit of Oral Health Sciences, University of Oulu, Finland

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials